Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study Evaluating the Safety and Efficacy of AR-15512 (COMET-3)

ClinicalTrials.gov ID: NCT05360966

Public ClinicalTrials.gov record NCT05360966. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 3:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Study Evaluating the Safety and Efficacy of AR-15512, a Cold Thermoreceptor Modulator, for the Treatment of Dry Eye Disease (COMET-3)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This will be a Phase 3, multicenter, vehicle-controlled, double-masked, randomized study conducted at approximately 20 sites in the United States. All subjects enrolled will have dry eye disease (DED). The study will consist of Screening (Day -14) and Baseline (Day 1) visits as well as visits at Day 7, Day 14, Day 28, and Day 90 (Study Exit) for an individual duration of participation of approximately 15 weeks.

Study identification

NCT ID
NCT05360966
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Aerie Pharmaceuticals
Industry
Enrollment
467 participants

Conditions and interventions

Eligibility (public fields only)

Age range
30 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 18, 2022 (Actual)
Primary completion
Oct 17, 2023 (Actual)
Completion
Oct 17, 2023 (Actual)
Last update posted
Jul 23, 2025

2022 – 2023

United States locations

U.S. sites
23
U.S. states
12
U.S. cities
23
Facility City State ZIP Site status
Reeve Woods Eye Center Chico California 95926 —
NVision Clinical Research, LLC Fullerton California 92835 —
Eye Research Foundation Newport Beach California 92663 —
Shultz Vision Northridge California 91325 —
NVision Clinical Research, LLC Torrance California 90505 —
Argus Research Center Cape Coral Florida 33904 —
Jackson Eye Lake Villa Illinois 60046 —
Wyse Eyecare Northbrook Illinois 60062 —
Pankratz Eye Institute Columbus Indiana 47203 —
Andover Eye Associates Andover Massachusetts 01810 —
Boston Vision Milford Massachusetts 01757 —
Andover Eye Associates - Raynham Raynham Massachusetts 02767 —
AdvanceMed Clinical Research Las Vegas Nevada 89123 —
NVision Clinical Research, LLC Rochester New York 14624 —
Oculus Research Garner North Carolina 27529 —
Wilmington Eye Leland North Carolina 28451 —
Pure Ophthalmic Research Mint Hill North Carolina 28227 —
Erie Retina Research Erie Pennsylvania 16507 —
Andover Eye Associates Warwick Rhode Island 02886 —
Keystone Research Austin Texas 78731 —
Axis Clinicals Dallas Texas 75243 —
Piedmont Eye Center Lynchburg Virginia 24502 —
Virginia Eye Institute Richmond Virginia 23230 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05360966, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 23, 2025 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05360966 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →